Q3 and Q4 2019 Installations and Fleet Orders Coming Earlier Than Expected

HOUSTON, June 3, 2019 /PRNewswire/ — Envirocleanse LLC, division of Charter Brokerage LLC, a BERKSHIRE HATHAWAY company has received multiple 2019 sales and installation requests for its patented inTank™ Ballast Water Treatment System (BWTS).  inTank™ is the only Type Approved BWTS which treats water during the voyage, leaving port activities unchanged.

Jim Stanka, President of Envirocleanse LLC, comments:

“We have always anticipated a strong acceptance in the market place since inTank™ is the only Type Approved system that treats during voyage, rather than in-port during cargo operations.  However, we are pleasantly surprised that multiple orders, installations, and fleet commitments are happening as quickly as Q3 and Q4 2019.  We continue to believe the largest bell curve for orders will be in the 2021-2024 time period but are grateful that our global footprint was well in place to handle these urgent needs by customers.”

The Envirocleanse LLC inTank™ BWTS is second generation thinking which stands out from the rest of the industry because inTank™ completely eliminates the operational and commercial risks associated with completing ballast treatment during cargo operations.  inTank™ treats and neutralizes in the tank. This means technical compliance with the US and International discharge standard is achieved before discharge. inTank™ also allows the vessel to actively control potential regrowth for as long as ballast remains in the tanks. All these attributes allow inTank™ to provide the most certainty of compliance with the least impact to operations.

Matt Hughes, Sr. Vice-President of Sales and Marketing adds that inTank™ is fully compliant with revised G8 standards, one of only a handful of companies that will not have to submit additional efficacy test data to the IMO.  This means future customers can choose the inTank™ BWTS without worry or concern that the system will not pass the stringent re-growth testing requirements now in place.

About Envirocleanse LLC
The mission of Envirocleanse is to provide a superior ballast water treatment system that assists companies around the world to perform at the highest safety, compliance and reliability standards without impacting cargo operations.  Envirocleanse LLC is a division of Charter Brokerage LLC, a BERKSHIRE HATHAWAY company.

www.eco-enviro.com

Logo – https://mma.prnewswire.com/media/623962/Envirocleanse_Logo.jpg

FANGCHENGGANG, China, June 3, 2019 /PRNewswire/ — As reported by CRI Online: Recently, the International Medical Innovation and Cooperation Forum (China-Shanghai Cooperation Organization), co-sponsored by the Shanghai Cooperation Organization Good-Neighborly Friendship and Cooperation Committee and the People’s Government of Guangxi Zhuang Autonomous Region, was held in Fangchenggang City.

This is the first time that the Shanghai Cooperation Organization (SCO) has organized an international medical innovation and cooperation forum, with the theme of health, cooperation, innovation, sharing and building a platform for medical innovation and cooperation under the framework of the SCO.

Topics such as national health, disaster relief, disease prevention and control, medical services, traditional medicine, health management, medical and nursing, medical education and scientific research, and medical personnel exchanges were discussed, and a broad consensus was reached.

Multiple cooperation agreements were reached in the Forum. The Fangchenggang Declaration of the International Medical Innovation Cooperation Forum (China-Shanghai Cooperation Organization) was also released. It pointed out that the Forum decided to establish the “China-Shanghai Cooperation Organization Medical Innovation and Cooperation Committee” in Shanghai, China.

The Forum welcomes the participants in the initiative to establish the “International Medical Open Experimental Zone (China)” in Fangchenggang City, and believes this experimental zone will provide unprecedented opportunities for regional and national medical cooperation.

Fangchenggang City has proposed the idea of “one district and two cities”, namely advocating the establishment of an international medical open experimental zone across the city, creating an international pharmaceutical manufacturing town and an international medical and health-care town in the experimental zone, which includes a China-India pharmaceutical manufacturing industrial park, US-Europe new special medicine manufacturing industrial park and Russian pharmaceutical industrial park.

As of now, Fangchenggang City is promoting the construction of a 67-hectare China-India pharmaceutical manufacturing industrial park.

More than 800 government officials, medical specialists and scholars from 21 countries such as the Philippines, Thailand and Ukraine participated in the forum. The participants are all SCO member states, observer countries and dialogue partners.

Photo – https://mma.prnewswire.com/media/896331/China_India_forum.jpg

FANGCHENGGANG, China, June 3, 2019 /PRNewswire/ — As reported by CRI Online: Recently, the International Medical Innovation and Cooperation Forum (China-Shanghai Cooperation Organization), co-sponsored by the Shanghai Cooperation Organization Good-Neighborly Friendship and Cooperation Committee and the People’s Government of Guangxi Zhuang Autonomous Region, was held in Fangchenggang City.

This is the first time that the Shanghai Cooperation Organization (SCO) has organized an international medical innovation and cooperation forum, with the theme of health, cooperation, innovation, sharing and building a platform for medical innovation and cooperation under the framework of the SCO.

Topics such as national health, disaster relief, disease prevention and control, medical services, traditional medicine, health management, medical and nursing, medical education and scientific research, and medical personnel exchanges were discussed, and a broad consensus was reached.

Multiple cooperation agreements were reached in the Forum. The Fangchenggang Declaration of the International Medical Innovation Cooperation Forum (China-Shanghai Cooperation Organization) was also released. It pointed out that the Forum decided to establish the “China-Shanghai Cooperation Organization Medical Innovation and Cooperation Committee” in Shanghai, China.

The Forum welcomes the participants in the initiative to establish the “International Medical Open Experimental Zone (China)” in Fangchenggang City, and believes this experimental zone will provide unprecedented opportunities for regional and national medical cooperation.

Fangchenggang City has proposed the idea of “one district and two cities”, namely advocating the establishment of an international medical open experimental zone across the city, creating an international pharmaceutical manufacturing town and an international medical and health-care town in the experimental zone, which includes a China-India pharmaceutical manufacturing industrial park, US-Europe new special medicine manufacturing industrial park and Russian pharmaceutical industrial park.

As of now, Fangchenggang City is promoting the construction of a 67-hectare China-India pharmaceutical manufacturing industrial park.

More than 800 government officials, medical specialists and scholars from 21 countries such as the Philippines, Thailand and Ukraine participated in the forum. The participants are all SCO member states, observer countries and dialogue partners.

Photo – https://mma.prnewswire.com/media/896331/China_India_forum.jpg

NAIROBI, Kenya, June 3, 2019 /PRNewswire/ — Globeleq, a power sector leader in Africa, has reached financial close of the 40 MW_AC (52 MW p) Malindi Solar photovoltaic (PV) project in Malindi, Kenya and is commencing construction of the plant.

The US$69 million project is located in Langobaya, Malindi District, Kilifi County, about 120 kms north-east of Mombasa and is one of the first IPP owned utility scale solar power plants in Kenya to begin construction.  Electricity will be sold through a 20-year agreement with the national distribution company, Kenya Power.

Globeleq has been working with the project originator, Africa Energy Development Corporation (AEDC), who will retain 10% ownership of the project, and its partner, IDEA Power, to bring the project to construction by providing equity, project development and construction management experience.  CDC, the UK’s development finance institution, as the mandated lead arranger, has sourced US$52 million in debt financing including $20 million from DEG, the German development finance institution.

Paul Hanrahan, Globeleq’s CEO said: “The attractive investment climate combined with strong local community support sets the stage for this important project as well as future investments in Kenya. We are extremely pleased to be making this investment into the Kenyan energy sector.”

Zohrab Mawani, AEDC’s Director added: “AEDC is excited to have reached this significant milestone with the Malindi project.  Working with our partners, we are very pleased to contribute to sustainable economic development in Kenya and look forward to continued growth in Sub Saharan Africa.”

The Engineering, Procurement and Construction company, Sterling and Wilson Solar is commencing with civil and electrical construction works. Land rights, environmental and local permits have been obtained, and the project team has been conducting regular community consultations.  Construction will take around twelve months with the plant reaching commercial operations in mid-2020.

It is expected the project will need around 250 workers during construction, many of which will be hired from the local community.  Globeleq will oversee the construction and operations of the power plant.

About Globeleq
Globeleq is a leading developer, owner and operator of electricity generation in Africa. Since 2002, its experienced team of professionals have built a diverse portfolio of independent power plants, The company owns and operates nearly 1,400 MW in 12 locations across 5 countries, with a further 2,000 MW of power projects in development . 

Photo – https://mma.prnewswire.com/media/896234/Globeleq_Solar_Project.jpg
Logo – https://mma.prnewswire.com/media/612609/GLobeleq_Logo.jpg